In this corporate acquisition of a $40 million revenue health-tech division – carving out from a PE-owned group – the target’s structure and commercial relationships required valuation input and integration strategy.

BML completed this dual-report (due diligence and value creation) on operations, technology, data, cyber and IP. Using insights from the review stage, we detailed the approach to addressing IP constraints and operating model complexities, as well as designing a pragmatic carveout and integration strategy.